Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares

19th Dec 2024 17:24

RNS Number : 8345Q
Tate & Lyle PLC
19 December 2024
 

Transactions in Own Securities

 

19 December 2024

Tate & Lyle plc (the "Company") announces that it has purchased the following number of its ordinary shares from Merrill Lynch International ("BofA") as part of its share buyback programme announced on 20 June 2024 (the "Programme").

Date of purchase:

19 December 2024

Number of ordinary shares of £0.2916666667 each purchased:

175,861

Highest price paid per share (£):

6.86

Lowest price paid per share (£) :

6.78

Volume weighted average price paid per share (£):

6.82

The repurchased shares will be held in treasury. Following the purchase of these shares, the Company holds 29,446,236 of its ordinary shares in treasury and has 447,277,985 ordinary shares in issue (excluding treasury shares).

Aggregated Information

 

Date

Trading venue

Volume weighted average price (£ per share)

Number of Shares Purchased

 

19 December 2024

London Stock Exchange

6.83

146,600

19 December 2024

Chi-X (CXE)

6.82

23,392

19 December 2024

BATS (BXE)

6.81

5,869

Transaction Details

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by BofA on behalf of the Company as part of the Programme is detailed on the attached:

http://www.rns-pdf.londonstockexchange.com/rns/8345Q_1-2024-12-19.pdf

The LEI reference for Tate & Lyle PLC is 2138008K14474WPKZ244.

For further information please contact:

Christopher Marsh, VP, Investor Relations

Mobile: +44 (0)7796 192 688

Nick Hasell (FTI Consulting), Media Relations

Mobile: +44 (0)7825 523 383

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSTLBRTMTTBBBI

Related Shares:

Tate & Lyle
FTSE 100 Latest
Value8,634.80
Change51.99